MBX Operating Income vs Total Current Liabilities Analysis
| MBX Stock | 18.50 1.99 12.05% |
MBX Biosciences, financial indicator trend analysis is infinitely more than just investigating MBX Biosciences, Common recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MBX Biosciences, Common is a good investment. Please check the relationship between MBX Biosciences, Operating Income and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MBX Biosciences, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Operating Income vs Total Current Liabilities
Operating Income vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MBX Biosciences, Common Operating Income account and Total Current Liabilities. At this time, the significance of the direction appears to have pay attention.
The correlation between MBX Biosciences,'s Operating Income and Total Current Liabilities is -1.0. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of MBX Biosciences, Common, assuming nothing else is changed. The correlation between historical values of MBX Biosciences,'s Operating Income and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of MBX Biosciences, Common are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Operating Income i.e., MBX Biosciences,'s Operating Income and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | -1.0 |
| Relationship Direction | Negative |
| Relationship Strength | Strong |
Operating Income
Operating Income is the amount of profit realized from MBX Biosciences, Common operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of MBX Biosciences, Common is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Current Liabilities
Total Current Liabilities is an item on MBX Biosciences, balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of MBX Biosciences, Common are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from MBX Biosciences,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MBX Biosciences, Common current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MBX Biosciences, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Selling General Administrative is likely to drop to about 5.8 M in 2024. Issuance Of Capital Stock is likely to drop to about 57.8 M in 2024
| 2010 | 2023 | 2024 (projected) | Total Operating Expenses | 25.2M | 35.3M | 33.3M | Research Development | 21.4M | 28.5M | 27.5M |
MBX Biosciences, fundamental ratios Correlations
Click cells to compare fundamentals
MBX Biosciences, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MBX Stock Analysis
When running MBX Biosciences,'s price analysis, check to measure MBX Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences, is operating at the current time. Most of MBX Biosciences,'s value examination focuses on studying past and present price action to predict the probability of MBX Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences,'s price. Additionally, you may evaluate how the addition of MBX Biosciences, to your portfolios can decrease your overall portfolio volatility.